Cargando…

Aspirin in the era of immunotherapy

Detalles Bibliográficos
Autores principales: Hamada, Tsuyoshi, Giannakis, Marios, Ogino, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650268/
https://www.ncbi.nlm.nih.gov/pubmed/29088713
http://dx.doi.org/10.18632/oncotarget.20877
_version_ 1783272671394398208
author Hamada, Tsuyoshi
Giannakis, Marios
Ogino, Shuji
author_facet Hamada, Tsuyoshi
Giannakis, Marios
Ogino, Shuji
author_sort Hamada, Tsuyoshi
collection PubMed
description
format Online
Article
Text
id pubmed-5650268
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-56502682017-10-30 Aspirin in the era of immunotherapy Hamada, Tsuyoshi Giannakis, Marios Ogino, Shuji Oncotarget Editorial Impact Journals LLC 2017-09-14 /pmc/articles/PMC5650268/ /pubmed/29088713 http://dx.doi.org/10.18632/oncotarget.20877 Text en Copyright: © 2017 Hamada et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Hamada, Tsuyoshi
Giannakis, Marios
Ogino, Shuji
Aspirin in the era of immunotherapy
title Aspirin in the era of immunotherapy
title_full Aspirin in the era of immunotherapy
title_fullStr Aspirin in the era of immunotherapy
title_full_unstemmed Aspirin in the era of immunotherapy
title_short Aspirin in the era of immunotherapy
title_sort aspirin in the era of immunotherapy
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650268/
https://www.ncbi.nlm.nih.gov/pubmed/29088713
http://dx.doi.org/10.18632/oncotarget.20877
work_keys_str_mv AT hamadatsuyoshi aspirinintheeraofimmunotherapy
AT giannakismarios aspirinintheeraofimmunotherapy
AT oginoshuji aspirinintheeraofimmunotherapy